Factors affecting pretransplant muscle strength in allogeneic stem cell transplant candidates prior transplantation

被引:0
作者
Limbach, Matthias [1 ,2 ,3 ,4 ]
Kuehl, Rea [1 ,2 ,3 ]
Koeppel, Maximilian [1 ,2 ,3 ,4 ]
Dreger, Peter [5 ]
Luft, Thomas [5 ]
Bohus, Martin [6 ]
Wiskemann, Joachim [1 ,2 ,3 ,4 ]
机构
[1] Heidelberg Univ Hosp, Dept Med Oncol, Neuenheimer Feld 460, D-69120 Heidelberg, Germany
[2] German Canc Res Ctr, Natl Ctr Tumor Dis Heidelberg, Neuenheimer Feld 460, D-69120 Heidelberg, Germany
[3] Univ Med Ctr Heidelberg, Neuenheimer Feld 460, D-69120 Heidelberg, Germany
[4] Heidelberg Univ, Inst Sports & Sport Sci, Neuenheimer Feld 700, Heidelberg, Germany
[5] Heidelberg Univ Hosp, Dept Medicine5, Heidelberg, Germany
[6] Cent Inst Mental Hlth, Mannheim, Germany
关键词
Exercise; Allogeneic stem cell transplantation; Oncology; Muscle strength; Pretransplantation; IMPACT; MASS; RELIABILITY; VALIDITY; FITNESS; SCT;
D O I
10.1007/s00520-024-09140-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Physical performance is crucial for prognosis after allogeneic hematopoietic stem cell transplantation (allo-HCT). Cardiorespiratory fitness has already been shown to have prognostic value, and there is increasing evidence that muscle strength and associated parameters (e.g., sarcopenia) are also of clinical relevance. Therefore, there is a need for the quantification of muscle strength and defining risk factors for reduced performance values. Methods: Maximal voluntary isokinetic (MVIC) and isometric (MIPT) muscle strength was assessed 2.4 +/- 7.1 days prior admission for allo-HCT with a stationary isokinetic testing machine (IsoMed2000). We calculated percentiles for knee extension and hip flexion using healthy reference values. Regression models were used to identify predictors for reduced muscle strength including gender, age, body mass index (BMI), number of previous cardiotoxic therapies, number of previous transplantations, comorbidity index (HCT-CI), hemoglobin level, and physical activity. Results: Data of 212 patients (male n = 143, female n = 69), with a mean age of 54.49 +/- 11.4, revealed considerably deviations from healthy reference values. Patients were located in the following percentiles: MVICKnee 37.5 +/- 30.3, MVICHip 39.5 +/- 31.3 and MIPTKnee 22.9 +/- 26.5; MIPTHip 22.6 +/- 27.4. Sub-group analyses showed that patients with younger age and male gender possess the highest deviations. Muscle strength values were significantly (p < 0.05) influenced by age, female gender, lower BMI, and higher HCT-CI. Conclusion: Muscle strength is considerably reduced immediately prior to allo-HCT. Identified patient characteristics for reduced muscle strength point to the population that should be primarily targeted with exercise respectively resistance training interventions prior to allo-HCT to contribute to a well prepared transplant candidate.
引用
收藏
页数:12
相关论文
共 46 条
[1]   Impact of Sarcopenia on Adverse Outcomes After Allogeneic Hematopoietic Cell Transplantation [J].
Armenian, Saro H. ;
Xiao, Meisi ;
Teh, Jennifer Berano ;
Lee, Brandyn ;
Chang, Howard A. ;
Mascarenhas, Kristen ;
Lee, Sean ;
Iukuridze, Alex ;
Xie, Jack J. ;
Scott, Jessica M. ;
Jones, Lee W. ;
Wong, F. Lennie ;
Forman, Stephen J. ;
Nakamura, Ryotaro .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (08) :837-844
[2]   Cancer-induced muscle wasting: latest findings in prevention and treatment [J].
Aversa, Zaira ;
Costelli, Paola ;
Muscaritoli, Maurizio .
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2017, 9 (05) :369-382
[3]   Muscle dysfunction in cancer patients [J].
Christensen, J. F. ;
Jones, L. W. ;
Andersen, J. L. ;
Daugaard, G. ;
Rorth, M. ;
Hojman, P. .
ANNALS OF ONCOLOGY, 2014, 25 (05) :947-958
[4]   Cardiorespiratory fitness and muscle strength in pancreatic cancer patients [J].
Clauss, Dorothea ;
Tjaden, Christine ;
Hackert, Thilo ;
Schneider, Lutz ;
Ulrich, Cornelia M. ;
Wiskemann, Joachim ;
Steindorf, Karen .
SUPPORTIVE CARE IN CANCER, 2017, 25 (09) :2797-2807
[5]   Isokinetic and isometric muscle strength in a healthy population with special reference to age and gender [J].
Danneskiold-Samsoe, B. ;
Bartels, E. M. ;
Bulow, P. M. ;
Lund, H. ;
Stockmarr, A. ;
Holm, C. C. ;
Watjen, I. ;
Appleyard, M. ;
Bliddal, H. .
ACTA PHYSIOLOGICA, 2009, 197 :1-68
[6]   Who is fit for allogeneic transplantation? [J].
Deeg, H. Joachim ;
Sandmaier, Brenda M. .
BLOOD, 2010, 116 (23) :4762-4770
[7]   Reliability and validity of the Biodex system 3 pro isokinetic dynamometer velocity, torque and position measurements [J].
Drouin, JM ;
Valovich-mcLeod, TC ;
Shultz, SJ ;
Gansneder, BM ;
Perrin, DH .
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY, 2004, 91 (01) :22-29
[8]   Assessing the clinical benefits of erythropoietic agents using area under the hemoglobin change curve [J].
Duh, MS ;
Lefebvre, P ;
Fastenau, J ;
Piech, CT ;
Waltzman, RJ .
ONCOLOGIST, 2005, 10 (06) :438-448
[9]   Inter- and Intrarater Reliability of Isokinetic Thigh Muscle Strength Tests in Postmenopausal Women With Osteopenia [J].
Eitzen, Ingrid ;
Hakestad, Kari Anne ;
Risberg, May Arna .
ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION, 2012, 93 (03) :420-427
[10]   Measurement and impact of comorbidity in older cancer patients [J].
Extermann, M .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2000, 35 (03) :181-200